Unicycive Therapeutics Inc.
UNCY | NASDAQ
$4.84
+$0.07 (+1.47%)
Sep 22, 2026, 10:05 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.46 | -1.41 | -0.68 | -0.45 | -3.08 | -33.78 |
PEG Ratio | 0.05 | 0.03 | -0.10 | -0.01 | -0.01 | -8 |
PS Ratio | n/a | n/a | 31.56 | 8.55 | n/a | n/a |
PB Ratio | 3.04 | 7.16 | -5.59 | -17.45 | 1.87 | -28.54 |
P/FCF Ratio | -2.92 | -1.86 | -1.16 | -0.52 | -5.33 | -52.25 |
P/OCF Ratio | -2.93 | -1.86 | -1.17 | -0.52 | -5.36 | -52.25 |
OCF/S Ratio | n/a | n/a | -2.71K | -1.65K | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.10 | -0.21 | -0.43 | 0.02 | -0.94 |
Quick Ratio | 2.59 | 1.28 | 0.76 | 0.81 | 8.75 | 0.07 |
Current Ratio | 2.59 | 1.28 | 0.76 | 0.81 | 8.75 | 0.07 |
Asset Turnover | n/a | n/a | 0.05 | 0.34 | n/a | n/a |
Interest Coverage | -415.73 | -452.35 | -253.34 | -3.01K | -14.29 | -8.28 |
Return on Equity | -87.94% | -494.27% | 801.89% | 3.88K% | -60.77% | 93.90% |
Return on Assets | -54.05% | -115.98% | -215.24% | -640.81% | -53.44% | -1.23K% |
Return on Invested Capital | -97.11% | -391.48% | 692.93% | 6.81K% | -53.37% | -4.7K% |
Dividend Yield | n/a | 2.06% | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | -2.98% | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | -3.53% | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 100% | 100% | n/a | n/a |
Net Profit Margin | n/a | n/a | -4.53K% | -1.9K% | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -4.53K% | -1.9K% | n/a | n/a |
Operating Profit Margin | n/a | n/a | -3.08K% | -1.9K% | n/a | n/a |
FCF Margin | n/a | n/a | -2.71K% | -1.65K% | n/a | n/a |
EBITDA Margin | n/a | n/a | -4.47K% | -1.88K% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove UNCY